HYDREA 830 HYDREA 830 (Hydrea 500 mg)

Generic Name: hydroxyurea

Pill imprint HYDREA 830 HYDREA 830 has been identified as Hydrea 500 mg.

Hydrea is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydrea 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for HYDREA 830 HYDREA 830

Hydrea 500 mg HYDREA 830 HYDREA 830
Hydrea
Generic Name:
hydroxyurea
Imprint:
HYDREA 830
HYDREA 830
Strength:
500 mg
Color:
Pink & Turquoise
Size:
22.00 mm
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-0830
Inactive Ingredients:
citric acid monohydrate
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
D&C Red No. 28
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-1367 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)